A 28-Week Open Label Extension Study Evaluating Safety and Tolerability of Donepezil Hydrochloride in Subjects With Mild Cognitive Impairment

Clinical trial NCT00934375 · COMPLETED

Trial details

NCT number: NCT00934375
Sponsor: Eisai Inc.
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Mild Cognitive Impairment

Start date: 2006-02-01
Primary completion: 2007-09-01
Enrollment: 145

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.